A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Summary

The primary objective of this study is to evaluate the pharmacokinetics (PK), tolerabilty and safety of a single dose of ID-085 in subjects with mild, moderate, and severe renal function impairment compared to healthy subjects

Timeline

Start

2019-04-29

Primary completion

2019-08-22

Completion

2019-08-22

Drugs

Indications